Dyspnea and hypotension after hip surgery
A 72-year-old man, 9 days after hemiarthroplasty for a femoral neck fracture, presents with sudden dyspnea and pleuritic chest pain. He is on enoxaparin 40 mg once daily since surgery. Vitals: BP 92/60 mmHg, HR 118/min, RR 28/min, SpO2 89% on room air, temperature 37.4 °C. Jugular venous pressure is elevated, the right leg is 3 cm larger than the left, and the ECG shows sinus tachycardia with an S1Q3T3 pattern. Chest radiograph is clear. Creatinine 1.4 mg/dL (baseline 0.9), eGFR about 45 mL/min. Bedside troponin is mildly elevated. The nearest CT pulmonary angiography suite is 45 minutes away; the patient is too unstable for transport without intervention.
1. What is the most likely diagnosis, and how do the clinical findings and the timing of enoxaparin prophylaxis support it?
Read the worked answer
Most likely diagnosis: intermediate-high-risk (submassive) pulmonary embolism.
Reasoning chain:
- Sudden dyspnea, pleuritic pain, tachycardia and hypoxia 9 days post-orthopedic surgery fit the classic postoperative VTE window (peak around days 5–10).
- Unilateral leg swelling supports a deep vein thrombosis source.
- S1Q3T3 is neither sensitive nor specific, but it is consistent.
- Elevated JVP with a clear chest radiograph points to right ventricular strain rather than pneumonia or edema.
- Mild troponin elevation plus hypotension (systolic < 100) indicate RV strain and place him in an intermediate-high or high-risk category, not low-risk.
Important nuance: enoxaparin 40 mg daily is prophylactic, not therapeutic. Its presence does not exclude PE; it only modestly lowers incidence. The exam trap is assuming prophylaxis rules out the diagnosis.
2. How should immediate management proceed, given the transport constraint and reduced renal function?
Read the worked answer
Stabilize first, image when safe.
- Anticoagulation now: start therapeutic parenteral anticoagulation without waiting for imaging, because the pretest probability is high and delay is harmful. With eGFR ~45 mL/min, unfractionated heparin or enoxaparin with renal dose adjustment is acceptable; UFH is preferable if thrombolysis or surgery may follow, because it can be stopped and reversed quickly.
- Risk stratification: obtain bedside echocardiography (RV dilation, McConnell sign) and serial troponin/BNP. This replaces some of the information CTPA would provide and can be done at the bedside.
- Oxygen and cautious fluids: keep SpO2 ≥ 90%; use small fluid boluses only if there is clear hypovolemia, since overfilling a strained RV worsens output.
- Escalation: if he remains hypotensive despite these measures (systolic < 90 or a drop > 40 mmHg), he meets high-risk criteria and systemic thrombolysis is indicated; if thrombolysis is contraindicated, catheter-directed therapy or surgical embolectomy should be arranged.
- Transport: only after stabilization, with monitoring and resuscitation equipment available.
The key judgment is that a 45-minute transport delay must not delay anticoagulation or risk stratification.
3. How should the duration and choice of long-term anticoagulation be decided, and what follow-up is required?
Read the worked answer
Long-term plan
- Continue anticoagulation for at least 3 months; the provoking factor (major orthopedic surgery) is transient, so a 3-month course is generally sufficient if the trigger is clearly resolved.
- Choice: a direct oral anticoagulant is preferred over warfarin in most patients, but renal function (eGFR ~45) and drug interactions must be checked; apixaban or rivaroxaban require dose review. If renal function declines further, warfarin may be safer.
- Follow-up: reassess at 3 months for residual symptoms, consider venous ultrasound if leg swelling persists, and evaluate whether the episode was truly provoked. If unprovoked features emerge, extend anticoagulation and screen for malignancy per guidelines.
- Educate on bleeding warning signs and avoid NSAIDs.
The exam point is that provoking factors change duration; renal function changes drug choice.